A Phase I/II Study of Active Immunotherapy With CEA(6D)VRP Vaccine(AVX701)in Patients With Advanced or Metastatic Malignancies Expressing CEA or Stage III Colon Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 08 Dec 2015
At a glance
- Drugs AVX 701 (Primary)
- Indications Cancer
- Focus Adverse reactions
- Acronyms CEA(6D)VRP
- Sponsors AlphaVax
- 11 Jul 2012 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 01 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Aug 2009 Planned number of patients changed from 24 to 36 as reported by ClinicalTrials.gov.